[Assisted reproductive technologies in HIV patients: Which results and which strategy in France in 2019?]

Gynecol Obstet Fertil Senol. 2019 Apr;47(4):362-369. doi: 10.1016/j.gofs.2019.02.001. Epub 2019 Feb 10.
[Article in French]

Abstract

With the use of antiretroviral therapy, HIV transmission from mother to fetus and between sexual partners has been significantly reduced, successively allowing pregnancy, then assisted reproductive technologies, and targeted unprotected sex among couples living with HIV. Since first French Morlat report in 2013, natural procreation is now possible under certain conditions for these couples living with HIV and the use of assisted reproductive technologies is increasingly limited to the treatment of infertility. While the results of intrauterine insemination seem satisfactory for serodiscordant couples living with HIV, in vitro fertilization results appear to be unfavorable when the woman is infected with HIV. In vitro fertilization results appear to be comparable to those in general population when only the man is infected with HIV. It can be assumed that ovaries are impacted by the treatment and/or the HIV in infected women.

Keywords: Assistance médicale à la procréation (AMP); Assisted reproductive technologies (ART); FIV; HIV; IVF; Infertility; Infertilité; Inséminations; VIH.

MeSH terms

  • Contraindications, Procedure
  • Female
  • France
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control
  • Infertility / therapy*
  • Male
  • Reproductive Techniques, Assisted
  • Semen / virology